JP2021512926A5 - - Google Patents
Info
- Publication number
- JP2021512926A5 JP2021512926A5 JP2020542907A JP2020542907A JP2021512926A5 JP 2021512926 A5 JP2021512926 A5 JP 2021512926A5 JP 2020542907 A JP2020542907 A JP 2020542907A JP 2020542907 A JP2020542907 A JP 2020542907A JP 2021512926 A5 JP2021512926 A5 JP 2021512926A5
- Authority
- JP
- Japan
- Prior art keywords
- free acid
- group
- absence
- reaction conditions
- under suitable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862628580P | 2018-02-09 | 2018-02-09 | |
| US62/628,580 | 2018-02-09 | ||
| PCT/US2019/017448 WO2019157426A1 (en) | 2018-02-09 | 2019-02-11 | Synthesis of 4-chlorokynurenines and intermediates |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021512926A JP2021512926A (ja) | 2021-05-20 |
| JP2021512926A5 true JP2021512926A5 (cg-RX-API-DMAC7.html) | 2022-02-22 |
| JP7431163B2 JP7431163B2 (ja) | 2024-02-14 |
Family
ID=67548039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020542907A Active JP7431163B2 (ja) | 2018-02-09 | 2019-02-11 | 4-クロロキヌレニンおよび中間体の合成 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11427530B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3749638B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7431163B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN112236412B (cg-RX-API-DMAC7.html) |
| CA (1) | CA3127220C (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019157426A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112236412B (zh) * | 2018-02-09 | 2024-01-30 | 维斯塔津治疗公司 | 4-氯代犬尿氨酸及中间体的合成 |
| WO2022082100A1 (en) * | 2020-10-16 | 2022-04-21 | Vistagen Therapeutics, Inc. | Cocrystals of l-4-chlorokynurenine, compositions and therapeutic uses thereof |
| CA3241944A1 (en) * | 2021-12-23 | 2023-06-29 | Syncrest Inc. | Organic zinc compound and production method for organic zinc compound |
| WO2023234187A1 (ja) * | 2022-05-31 | 2023-12-07 | シンクレスト株式会社 | 有機銅化合物の製造方法 |
| EP4695233A2 (en) * | 2023-04-14 | 2026-02-18 | Revolution Medicines, Inc. | Synthesis of ras inhibitors |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5484814A (en) | 1991-02-28 | 1996-01-16 | Merrell Dow Pharmaceuticals Inc. | NMDA antagonists |
| DK0624569T3 (da) * | 1991-02-28 | 1998-10-26 | Merrell Pharma Inc | MMDA-antagonister |
| GB9618349D0 (en) | 1996-09-03 | 1996-10-16 | Pharmacia Spa | N-substituted 2-amino-4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibitory activity |
| ATE249421T1 (de) * | 1997-06-23 | 2003-09-15 | Tanabe Seiyaku Co | Inhibitoren der alpha4-beta1 vermittelten zelladhäsion |
| CN1309702C (zh) * | 2005-10-28 | 2007-04-11 | 中国科学院上海有机化学研究所 | 犬尿氨酸酶的特异性抑制剂l-邻甲氧基苯甲酰基丙氨酸的合成方法 |
| CA3216579A1 (en) | 2013-01-22 | 2014-07-31 | Vistagen Therapeutics, Inc. | Dosage forms and therapeutic uses of l-4-chlorokynurenine |
| JP2016513718A (ja) | 2013-03-14 | 2016-05-16 | ヴィスタゲン セラピューティクス、インコーポレイテッド | キラルキヌレニン化合物及び中間体の合成 |
| CN107417558A (zh) | 2013-03-14 | 2017-12-01 | 维斯塔津治疗公司 | 用于合成手性犬尿氨酸化合物的方法 |
| US9666192B2 (en) | 2015-05-26 | 2017-05-30 | Nuance Communications, Inc. | Methods and apparatus for reducing latency in speech recognition applications |
| WO2017044516A1 (en) | 2015-09-08 | 2017-03-16 | Cephalon, Inc. | Prodrugs of chlorokynurenines |
| CN108139498B (zh) | 2015-10-15 | 2019-12-03 | 埃克森美孚上游研究公司 | 具有振幅保持的fwi模型域角度叠加 |
| WO2017065899A1 (en) * | 2015-10-16 | 2017-04-20 | Auspex Pharmaceuticals, Inc. | Deuterated chlorokynurenines for the treatment of neuropsychiatric disorders |
| CN107129444B (zh) * | 2016-02-29 | 2018-08-31 | 尚科生物医药(上海)有限公司 | (s)-2-叔丁氧羰基氨基-3-(4-氨甲酰基-2,6-二甲基苯基)丙酸制备方法 |
| CN112236412B (zh) * | 2018-02-09 | 2024-01-30 | 维斯塔津治疗公司 | 4-氯代犬尿氨酸及中间体的合成 |
-
2019
- 2019-02-11 CN CN201980021535.8A patent/CN112236412B/zh active Active
- 2019-02-11 JP JP2020542907A patent/JP7431163B2/ja active Active
- 2019-02-11 US US16/967,627 patent/US11427530B2/en active Active
- 2019-02-11 EP EP19750605.8A patent/EP3749638B1/en active Active
- 2019-02-11 CA CA3127220A patent/CA3127220C/en active Active
- 2019-02-11 WO PCT/US2019/017448 patent/WO2019157426A1/en not_active Ceased
- 2019-02-11 CN CN202410094204.XA patent/CN118026866A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5779592B2 (ja) | ラコサミドの合成のための方法 | |
| JP4770174B2 (ja) | グルタミン酸誘導体及びピログルタミン酸誘導体の製造方法並びに新規製造中間体 | |
| WO2005033064A1 (en) | Process of preparing o-carbamoyl compounds in the presence of active amine group | |
| CN108148044B (zh) | 酰胺类化合物及该化合物制备富马酸沃诺拉赞的方法 | |
| JP2020519680A (ja) | 4−メトキシピロール誘導体の中間体の製造方法 | |
| JP2016528271A (ja) | □新規な中間体を経由するビフェニルアラニノールの合成 | |
| WO2024092892A1 (zh) | 依度沙班中间体及其制备方法 | |
| US11427530B2 (en) | Synthesis of 4-chlorokynurenines and intermediates | |
| WO2019049824A1 (ja) | 保護l-カルノシン誘導体、l-カルノシン、および結晶性l-カルノシン亜鉛錯体の製造方法 | |
| JP7278775B2 (ja) | 長鎖化合物の製造方法 | |
| CN107810189B (zh) | 用于制备氮芥衍生物的方法 | |
| JP4149668B2 (ja) | β−ハロゲノ−α−アミノカルボン酸並びにフェニルシステイン誘導体及びその中間体の製造方法 | |
| US9790170B2 (en) | Method for preparing lacosamide | |
| WO2014141294A2 (en) | An improved process for the synthesis of melphalan and the hydrochloride salt | |
| US8853453B2 (en) | Processes for reducing impurities in lacosamide | |
| CN112272665A (zh) | 制备立他司特的方法 | |
| US11414411B2 (en) | Chemical process for manufacturing monobactam antibiotic and intermediates thereof | |
| JP4190879B2 (ja) | テアニンを製造するための新規な中間体 | |
| CN103702981B (zh) | 光学活性2-甲基脯氨酸衍生物的制造方法 | |
| WO2023033016A1 (ja) | アルギニン誘導体 | |
| JP2011057619A (ja) | 光学活性アミン化合物の製造方法、並びに、ジアステレオマー塩及びその製造方法 | |
| KR100880623B1 (ko) | 발사르탄의 제조방법 | |
| CN114845991A (zh) | 合成美法仑的方法 | |
| US20060264671A1 (en) | Process for the preparation of midodrine, pharmaceutically acceptable salts thereof and intermediates | |
| JP2019059688A (ja) | 結晶性l−カルノシン亜鉛錯体の製造方法 |